An improved rapid method for purification of herpes simplex virus DNA using cesium trifluoroacetate

Journal of Virological Methods

Volumn 58, Issue 1-2, 1996, Pages 193-198

  Ling, Jeng Yang ^a   Kienzle, Thomas E ^b,c   Stroop, William G ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Centrifugation; DNA isolation; DNA purification; HSV; Transfection

Indexed keywords

VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CENTRIFUGATION; CONTROLLED STUDY; DNA PURIFICATION; DNA TRANSFECTION; FREEZING; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS PURIFICATION;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0030026644     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(95)01985-5     Document Type: Article

References (31)

1. Berkowitz, C., Moyal, M., Rösen-Wolff, A., Darai, G. and Becker, Y. (1994) Herpes simplex virus type 1 (HSV-1) UL56 gene is involved in intraperitoneal pathogenicity to immunocompetent mice. Arch. Virol. 134, 73-83.
2. Bloom, D.C. and Stevens, J.G. (1994) Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J. Virol. 68, 3761-3772.
3. Brown, S.M., Subak-Sharpe, J.H., Harlan, J. and MacLean, A.R. (1992) Analysis of intrastrain recombination in herpes simplex virus type 1 strain 17 and herpes simplex virus type 2 strain HG52 using restriction endonuclease site as unselected markers and temperature-sensitive lesions as selected markers. J. Gen. Virol. 73, 293-301.
4. Chou, J., Kern, E.R., VVhitley, R.J. and Roizman, B. (1990) Mapping of herpes simplex virus-1 neurovirulence to gamma134.5, a gene nonessential for growth in culture. Science 250, 1262-1266.
5. Christensen, L.S. and Normann, P. (1992) A rapid method for purification of herpesvirus DNA. J. Virol. Meth. 37, 99-102
6. Chu, C.-T., Parris, D.S., Dixon, R.A.F., et al. (1979) Hydroxy lamine mutagenesis of HSV DNA and DNA fragments: introduction of mutations into selected regions of the viral genome. Virology 98, 168-181.
7. Day, S.P., Lausch, R.N. and Oakes, J.E. (1987) Nucleotide sequences important in DNA replication are responsible for differences in the capacity of two herpes simplex virus strains to spread from cornea to central nervous system. Current Eye Res. 6, 19-26.
8. Day, S.P., Lausch, R.N. and Oakes J.E. (1988) Evidence that the gene for herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system. Virology 163, 166-173.
9. Dix, R.D., McKendall, R.R. and Baringer, J.R. (1983) Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect. Immun. 840, 103-112.
10. Goldin, A.L. Sandri-Goldin, R.M., Levine, M. and Glorioso, J.C. (1991) Cloning of herpes simplex virus type 1 sequences representing the whole genome. J. Virol. 38, 50-58.
11. Goldstein, D.J. and Weller, S.K. (1988a) Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization on an ICP6 lacZ insertion mutant. J. Virol. 62, 196-205.
12. Goldstein, D.J. and Weiler, S.K. (1988b) An ICP6::LacZ insertional mutagen is used to demonstrate that the UL52 gene of herpes simplex virus type 1 is required for growth and DNA synthesis. J. Virol. 62, 2970-2977.
13. Ho, D.Y. and Mocarski, E.S. (1989) Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc. Natl. Acad. Sci. USA 86, 7596-7600.
14. Idowu, A.D., Fraser-Smith, E.B., Poffenberger, K.L. and Hermann, R.C. (1992) Deletion of the herpes simplex virus type I ribonucleotide reductase gene alters virulence and latency in vivo. Antiviral Res. 17, 145-156.
15. Izumi, K.M. and Stevens, J.G. (1990) Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J. Exp. Med. 172, 487-496.
16. Kintner, R.L. and Brandt, C.R. (1994) Rapid small scale isolation of herpes simplex virus DNA. J. Virol. Meth. 48, 189-196.
17. Lausch, R.N., Yeung, K.C., Miller, J.Z. and Oakes, J.E. (1990) Nucleotide sequences responsible for the inability of a herpes simplex virus type 2 strain to grow in human lymphocytes are identical to those responsible for its inability to grow in mouse tissues following ocular infection. Virology 176, 319-328.
18. MacLean, A.R., Ul-Fareed, M., Robertson, L., Harland, J. and Brown, S.M. (1991) Herpes simplex virus type-1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17 + between immediate early gene-1 and the a sequence. J. Gen. Virol. 72, 631-639.
19. Pignatti, P.F., Cassai, E., Meneguzzi, G., et al. (1992) Glycerol shock treatment facilitates purification of herpes simplex virus. J. Virol. Meth. 36, 151-158.
20. Rosen-Wolff, A., Scholz, J. and Darai, G. (1989) Organotropism of latent herpes simplex virus type 1 is correlated to the presence of a 1.5 kb RNA transcript mapped within the BamHI DNA fragment B (0.738-0.809 map units). Virus Res. 12, 43-52.
21. Sariemento, M. and Batterson, W.W. (1992) A new method for the isolation of herpes simplex virus type 2 DNA. Virology 74, 256-258.
22. Schleif, R.F. and Wensink, P.C. (1981) Practical Methods in Molecular Biology, Springer, New York, pp. 90-92.
23. Stroop, W.G. and Banks, M.C. (1992) The weakly virulent herpes simplex virus type 1 strain KOS-63 establishes peripheral and central nervous system latency following intranasal infection of rabbits, but poorly reactivates in vivo. J. Neuropathol. Exp. Neurol. 51, 550-559.
24. Stroop, W.G. and Banks, M.C. (1994) Herpes simplex virus type 1 strain KOS-63 does not cause acute or recurrent ocular disease and does not reactivate ganglionic latency in vivo. Acta Neuropathol. 87, 14-22.
25. Stroop, W.G. and Schaefer, D.C. (1986) Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. J. Infect. Dis. 153, 721-731.
26. Stroop, W.G. and Schaefer, D. (1987) Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization. Acta Neuropathol. (Berlin) 74, 124-132.
27. Stroop, W.G. and Schaefer, D.C. (1987a) Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus. Invest. Ophthalmol. Vis. Sci. 28, 229-237.
28. Stroop, W.G. and Schaefer, D.C. (1989) Neurovirulence of two clonally related herpes simplex virus type 1 strains in a rabbit seizure model. J. Neuropathol. Exp. Neurol. 48, 171-183.
29. Tenser, R.B., Miller, R.L. and Rapp, F. (1979) Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. Science 205, 915-917.
30. Thompson, R.L., Wagner, E.K., and Stevens, J.G. (1983) Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology 131, 180-192.
31. Walboomers, J.M.M. and Ter Shegget, J. (1976) A new method for the isolation of herpes simplex type 2 DNA. Virology 74, 256-258.